FLORIDA PROFESSIONALS IN INFECTION CONTROL 
Control, Education, Prevention, Surviellance

Legislative Update (as of 3/30/2018
Legislative updates by Barbara Russell, RN, MPH, CIC, FAPIC

FDA Ban on Triclosan and other Active Ingredients in Hands Soaps 
 At the end of 2017 the FDA issued new regulations banning the use of 24 active ingredients, including the commonly-used triclosan, in over-the-counter hand soaps and antiseptic washes that are often used in healthcare. 
Under the rule, which was first proposed in 2015, manufacturers will have one year to remove the active ingredients, take the product off the market or file a new drug application. 
The FDA determined the 24 banned ingredients are no longer appropriate for over-the-counter use since they are not recognized as safe and effective. 
FDA Commissioner Scott Gottlieb has been quoted as saying "Ensuring the safety and effectiveness of over-the-counter healthcare antiseptics has been a priority for the FDA, not only because these products are an important component of infection control strategies in healthcare settings, but also because of the role these products may play in contributing to antimicrobial resistance if they're not manufactured or used appropriately". 
At this time the FDA is deferring its decision on six of the most commonly used antiseptic ingredients — ethanol, isopropyl alcohol, povidone-iodine, benzalkonium chloride, benzethonium chloride, and chloroxylenol — while manufacturers test the safety and efficacy of those ingredients. 

CLICK HERE for more information 
  
 
  In Case You Missed It: FDA Safety Communication on Non-sterile Ultrasonic Gel    

 Back in 2012, the Food and Drug Administration (FDA) released a safety communication alerting healthcare facilities regarding the use of non sterile ultrasonic gel that was found to be contaminated with the bacteria Pseudomonas aeruginosa and Klebsiella oxytoca, which were transmitted to patients and caused serious complications. Additionally, in late 2016 a manufacturer of the gel was fined for selling contaminated gel which linked to infections. The FDA suggests limiting usage of a reusable bottle/tube and dating when opening to discard in 28 days. 
  


  
 
  Joint Commission Patient Safety Goal Revised to Include CRE      

  As of January 1st, 2018 The Joint Commission revised Patient Safety Goal 07.03.01 to add CRE to the list of MDROs that require monitoring, education, and prevention. “Education is to occur upon hiring or granting of initial privileges and periodically thereafter as determined by the facility”. Education must also extend to patients and/or family members who are infected or colonized with CRE. 
https://www.jointcommission.org/assets/1/6/NPSG_Chapter_HAP_Jan2018.pdf  
  
  


  
 
    2018 Florida Legislative Session    

The 2018 Florida Legislative Session has concluded and at this time nothing passed that directly impacts Infection Control. Except, maybe, that we won’t have to drive home in the dark.